Cargando…
From Epidemic Meningitis Vaccines for Africa to the Meningitis Vaccine Project
Background. Polysaccharide vaccines had been used to control African meningitis epidemics for >30 years but with little or modest success, largely because of logistical problems in the implementation of reactive vaccination campaigns that are begun after epidemics are under way. After the major g...
Autores principales: | Aguado, M. Teresa, Jodar, Luis, Granoff, Dan, Rabinovich, Regina, Ceccarini, Costante, Perkin, Gordon W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4639495/ https://www.ncbi.nlm.nih.gov/pubmed/26553665 http://dx.doi.org/10.1093/cid/civ593 |
Ejemplares similares
-
The Evolution of the Meningitis Vaccine Project
por: Tiffay, Kathleen, et al.
Publicado: (2015) -
A Vaccine Meets Its Promise: Success in Controlling Epidemic Meningitis in Sub-Saharan Africa
por: Sambo, Luis, et al.
Publicado: (2015) -
Meningococcal Meningitis Surveillance in the African Meningitis Belt, 2004–2013
por: Lingani, Clément, et al.
Publicado: (2015) -
Modeling Long-term Vaccination Strategies With MenAfriVac in the African Meningitis Belt
por: Karachaliou, Andromachi, et al.
Publicado: (2015) -
Regulatory Pathways That Facilitated Timely Registration of a New Group A Meningococcal Conjugate Vaccine for Africa's Meningitis Belt Countries
por: Dellepiane, Nora, et al.
Publicado: (2015)